Cannabinoids as Emergent Therapy Against COVID-19


Joseph McGrail, Lucı ́a Martı ́n-Banderas, and Matilde Dura ́n-Lobato

Published in Cannabis and Cannabinoid Research




The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory distress syndrome coronavirus 2(SARS-Cov-2), was identified for the first time in late 2019 in China, resulting in a global pandemic of massiveimpact. Despite a fast development and implementation of vaccination strategies, and the scouting of severalpharmacological treatments, alternative effective treatments are still needed. In this regard, cannabinoids repre-sent a promising approach because they have been proven to exhibit several immunomodulatory, anti-inflammatory, and antiviral properties in COVID-19 disease models and related pathological conditions. Thismini-review aims at providing a practical brief overview of the potential applications of cannabinoids so far iden-tified for the treatment and prevention of COVID-19, finally considering key aspects related to their technologicaland clinical implementation.

Full Paper>>

DOI: 10.1089/can.2022.0018


Citation: McGrail, J., Martín-Banderas, L., & Durán-Lobato, M. (2022). Cannabinoids as Emergent Therapy Against COVID-19. Cannabis and Cannabinoid Research.